Signacor Therapeutics Limited
- Company number
- NI717003
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 13 Jun 2024
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| PANKOVA, Natalie, Dr | Director | 4 Apr 2026 | |
| FOX, John Stephen, Dr | Director | 1 Jul 2025 | |
| NEESON, Darach | Director | 27 Mar 2025 | |
| GORMLEY, Julie Anne, Dr | Director | 27 Mar 2025 | |
| WATSON, Chris John | Director | 13 Jun 2024 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Chris John Watson | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
13 Jun 2024 |
Accounts
| Year ended | Net assets | Employees |
|---|---|---|
| 30 Jun 2025 | -£8,627 | 0 |
Connections
Directors’ other companies
- NEESON, Darach - Director at Ceathru Consulting Limited
- PANKOVA, Natalie, Dr - Director at Microsol Ltd
- PANKOVA, Natalie, Dr - Director at Serenatis Bio Limited
Companies at the same address
- Amply Discovery Limited (NI676691)
- Aramune Technologies Limited (NI676055)
- Generatr Limited (NI688790)
- Genome Diagnostics Ltd (NI667396)
- Glasport Bio Limited (NI677089)
- Gran Lab Limited (NI712589)
- Rapid-Myco Technologies Limited (NI679559)
- Sengenia Limited (NI064316)